Multiple Myeloma: Cutting-Edge Induction and Maintenance Therapies Lead to Improved Response Rates and Survival for Newly Diagnosed Patients

Name: Multiple Myeloma: Cutting-Edge Induction and Maintenance Therapies Lead to Improved Response Rates and Survival for Newly Diagnosed Patients
Uploaded: 2018-05-23T00:00:00+00:00
Description: Take a deep dive into therapy options for newly diagnosed myeloma patients: whether three drugs are better than two, the case for lenalidomide maintenance therapy, the many improvements in induction treatment, the future of immunotherapy, and more.

Overview

Take a deep dive into therapy options for newly diagnosed myeloma patients: whether three drugs are better than two, the case for lenalidomide maintenance therapy, the many improvements in induction treatment, the future of immunotherapy, and more.

Published

May 23, 2018

Created by

Related Presenters

Nina Shah, MD

Hematologist Oncologist

Dr. Nina Shah is a hematologist who specializes in the treatment of multiple myeloma, a type of cancer affecting the blood marrow.

View profile

Related Videos

Hope on the Horizon: Specialists Reveal New Approaches to Deadly Malignancies

Here’s an exciting look at recent improvements in our understanding and management of certain malignancies normally associated with a poor prognosis.

Anal Cancer: A Primary Care Guide to Risks and Screening

Infectious disease specialist Cristina Brickman, MD, MSCE, explains how common anal cancer really is, which HPV types are associated, which patient populations should be screened and when to start – and when to refer to a specialist. Videos ...

COVID-19 Consequences: Is the Ticker a Ticking Time Bomb?

Cardiologist Clifton Watt, MD, explores what’s now known about the SARS-CoV-2 variants as well as COVID-related multisystem inflammatory disorders, explains COVID’s potential for residual effects on the heart, and offers help with identifying ...

Pandemic Perplexities: Experts Address Safety, Cancer Care Delivery and Other Issues

With a panel representing oncology, epidemiology and infectious disease medicine, this presentation sorts out the data to illuminate issues in caring for immunocompromised, COVID-infected and cancer patients

Cancer Update: Safe Opioid Use and Innovations in Blood Cancer Therapies

In this three-part presentation, UCSF substance use experts offer prescribing strategies and tips on patient communication to ensure pain relief without enabling drug dependence.

Update on Liver Lesions: What Works in Managing HCC

Based on clear metrics, transplant hepatologist Neil Mehta, MD, presents diagnostic criteria for hepatocellular carcinoma, then shows how UCSF’s HCC team reaches decisions on treatment for individual cases – with plans ranging from resection ...

Strategies for Head and Neck Cancer: What to Look, Feel and Listen For

UCSF specialist Chase Heaton, MD, presents a guide to identifying head and neck cancers, including steps, tools and tips for a comprehensive exam; alarm-bell statements from your patients; and the one assumption you want to make about any neck lump.

Neck Knowledge: Diagnostics and Care for Growths in Adults

Dr. Patrick Ha, UCSF’s chief of head and neck surgical oncology, breaks down the neck’s complex anatomy and provides a case-based discussion of common growths – including developmental cysts, salivary gland disorders, thyroid masses and ...